Business Context and Reporting Period
This Form 6-K filing by Fresenius Medical Care AG & Co. KGaA covers the month of January 2011. The report serves to disclose a specific corporate financing event rather than providing comprehensive periodic financial results.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, or liquidity metrics. The primary financial data disclosed relates to a new debt issuance:
- US$-denominated senior unsecured notes: $650 million principal amount.
- Euro-denominated senior unsecured notes: €300 million principal amount.
- Total Principal Raised: $650 million + €300 million.
Material Changes
The material change reported is the pricing of the senior unsecured notes on January 27, 2011. This represents a significant increase in the company's debt obligations and cash inflow from financing activities. No comparative period data is provided in this specific filing.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or specific risk factors beyond the standard disclosure of the debt issuance. The document is a procedural report of the pricing event.
Investor Verification Checklist
- Verify the specific interest rates and maturity dates for the $650 million and €300 million notes, as these are not detailed in this summary text.
- Confirm the intended use of proceeds from this $950 million (combined) financing.
- Review the full Investor News Release (Exhibit 99.1) for detailed terms of the senior unsecured notes.
- Check subsequent filings for the impact of this new debt on the company's leverage ratios and liquidity position.